
The latest update is out from Bluejay Diagnostics ( ($BJDX) ). At its June 9, 2026 annual meeting, Bluejay stockholders approved a reverse stock split at a ratio between 1-for-2
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| BJDX | Bluejay Diagnostics | 1.70 | -18.62 | -91.63% |
| Name | Price | % Change | |
|---|---|---|---|
| $1.70 | -91.63% |

The latest update is out from Bluejay Diagnostics ( ($BJDX) ). At its June 9, 2026 annual meeting, Bluejay stockholders approved a reverse stock split at a ratio between 1-for-2

19:50 EST Bluejay Diagnostics (BJDX) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks

A stock trading at $500 and another struggling to stay above $1 might seem to have little in common, but both could be preparing to make the same corporate move:

An announcement from Bluejay Diagnostics ( ($BJDX) ) is now available. On October 13, 2026, Bluejay Diagnostics announced it had completed the establishment of a manufacturing site for Symphony cartridges

Bluejay Diagnostics ( ($BJDX) ) just unveiled an announcement. On October 6, 2026, Bluejay Diagnostics reported baseline clinical characteristics from its pivotal SYMON-II validation study, which enrolled 777 critically ill

Bluejay Diagnostics (BJDX) announced baseline clinical characteristics from the SYMON-II clinical validation study, highlighting a substantial and diverse population of critically ill patients and clinically meaningful mortality events for evaluating

Bluejay Diagnostics ( ($BJDX) ) has shared an update. On September 1, 2026, Bluejay Diagnostics entered a distribution, co-marketing and strategic partnership agreement with Lovell Government Services to support future

Bluejay Diagnostics (BJDX) and Lovell Government Services, a Service-Disabled Veteran-Owned Company specializing in federal healthcare distribution, announced a distribution, co-marketing and strategic partnership designed to support the introduction of Bluejay’s

Bluejay Diagnostics ( ($BJDX) ) has provided an announcement. On August 13, 2026, Bluejay Diagnostics reported second-quarter 2026 results, highlighting completion of targeted enrollment of 750 hospital patients in its

The latest announcement is out from Bluejay Diagnostics ( ($BJDX) ). On July 21, 2026, Bluejay Diagnostics announced it had completed patient enrollment in its SYMON-II multicenter clinical validation study
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.